drugset / Trial / NCT02287246
Efficacy of Extended-Release Liposomal Bupivacaine for Post-Operative Urogynecologic Surgery
RandomizedSingle-groupDouble-blindTreatment
Summary
To study post-operative efficacy of Exparel® for pain control in patients undergoing any Urogynecology surgery involving the posterior vaginal wall using a randomized, double-blinded placebo controlled trial.
Timeline
- Start
- 2014-10
- Primary completion
- 2016-11
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 20 ml | Other |
Indications
No indication recorded.